Fj. Branicki et Km. Chu, GASTRIC-CANCER IN ASIA - PROGRESS AND CONTROVERSIES IN SURGICAL-MANAGEMENT, Australian and New Zealand journal of surgery, 68(3), 1998, pp. 172-179
Considerable controversy surrounds the management of gastric cancer an
d this has largely overshadowed recent progress in our understanding o
f the epidemiology and molecular pathogenesis of the disease, and impr
ovements in diagnostic and staging techniques. Differences identifiabl
e in the molecular pathogenesis of the 'intestinal' and 'diffuse' type
s of gastric cancer may help to unravel the biological behaviour of va
riants and ultimately influence therapeutic strategies. Endoscopic ult
rasound is well established as being accurate for T staging and the in
troduction of laparoscopy, with or without ultrasound, is obviating un
necessary laparotomy in nonbleeding, non-obstructed patients. Controve
rsies in surgery encompass the role of laparoscopic surgery in early g
astric cancer, the extent of lymphadenectomy including para-aortic nod
al dissection, resection of en bloc contiguous organ involvement, panc
reatosplenectomy, left upper abdominal evisceration, and modes of reco
nstruction (pylorus-preserving gastrectomy, pouch formation) to enhanc
e quality of life. Whereas adjuvant chemotherapy does not impact favou
rably on survival, emphasis has now shifted to neoadjuvant (induction)
chemotherapy to downstage the disease. Preoperative regional chemothe
rapy and intra-operative hyperthermic chemotherapy or irradiation may
prove to be of benefit in patients with resectable disease, but some s
cepticism still exists as to the usefulness of biological response mod
ifiers (e.g. OK432, PSK) for adjuvant treatment. Ethical issues relati
ng to cultural differences in Asia sometimes mitigate against adequate
trial design (e.g. a surgery-alone control group or a no adjuvant the
rapy treatment group may be considered inappropriate) and this has und
erstandably hindered acceptance in Western countries of the value of c
urrent management practices in Asia. These issues and the need for ong
oing well-conducted randomized trials with prospective subset analysis
are now being addressed.